In addition, we observed that SWI/SNF composition in prostate cancer is not a hard-set feature; instead, specialized forms of SWI/SNF may assemble in cancer cells depending on their phenotype (Fig. 5). This evidence concerns the gene SMARCA1 and prostate cancer.